13F filer · CIK 19617 ↗
Jpmorgan Chase & Co
You are looking at Q1 2020. See the latest, Q2 2026 →
Reported value
$425.90B
−21% on the quarter before
Positions
5,335
422 new · 764 sold out
Top 10
17.7%
of the value
Est. gain
−$91.48B
on stocks held all quarter
Est. return
−20.5%
on those stocks since Q4 2019
Positions as of Mar 31, 2020, from Jpmorgan Chase & Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 27% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2019. Striped tiles are options.
Largest buys
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares S&P 500 Growth ETF~$1.67BAdded · 0.2% → 0.6%+10,129,671 shares
- Ishares S&P 500 Value ETF~$1.66BAdded · 0.2% → 0.5%+17,242,706 shares
- Ishares Core U.S. Aggregate~$1.14BAdded · 0.3% → 0.7%+9,898,454 shares
- Health Care Select Sector~$966.0MAdded · 0.1% → 0.4%+10,905,426 shares
- Ishares TrPUT~$900.4MAdded · 0.3% → 0.5%+8,588,200 underlying
- Ishares Russell 1000 Value E~$876.7MAdded · 0.0% → 0.2%+8,839,887 shares
- Ishares Russell 1000 Growth~$818.4MAdded · 0.1% → 0.3%+5,432,227 shares
- Ishares Us Treasury Bond ETF~$785.4MAdded · 0.0% → 0.2%+28,038,964 shares
- SPDR S&P Biotech ETF~$755.2MAdded · 0.0% → 0.2%+9,752,095 shares
- Ishares Iboxx Investment Gra~$739.1MAdded · 0.1% → 0.3%+5,984,410 shares
Largest sells
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrPUT~$5.92BCut · 1.9% → 0.6%−22,982,600 underlying
- ApplePUT~$2.43BCut · 0.6% → 0.1%−9,573,800 underlying
- Jpmorgan Betabuilders Japan ETF~$1.11BCut · 0.7% → 0.4%−54,324,207 shares
- Ishares 20 Year Treasury Bo~$1.10BCut · 0.4% → 0.4%−6,637,839 shares
- Microsoft~$933.1MCut · 2.5% → 2.9%−5,916,249 shares
- Jpmorgan Betabuilders Europe ETF~$921.0MCut · 0.7% → 0.4%−48,096,200 shares
- SPDR S&P 500 ETF Trust~$786.6MCut · 4.4% → 4.3%−3,051,720 shares
- Ingersoll-Rand Plc~$777.0MSold out · 0.1% → 0.0%−5,845,578 shares
- Ishares 7-10 Year Treasury B~$610.1MCut · 0.8% → 0.9%−5,022,480 shares
- Ishares TrCALL~$589.6MCut · 0.1% → 0.0%−7,650,000 underlying
Holdings
As of Mar 31, 2020. Changes are in shares against Dec 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrustFUND · shares −4.1% · price −19.9% | 4.3% | $18.30B | −$4.55B | ||||||||
| MicrosoftCOMMON · shares −7.1% · price +0.0% | 2.9% | $12.22B | +$776,544 | ||||||||
| AppleCOMMON · shares +5.0% · price −13.4% | 1.9% | $8.03B | −$1.18B | ||||||||
| AmazonCOMMON · shares +0.2% · price +5.5% | 1.8% | $7.69B | +$401.1M | ||||||||
| Vanguard Total Intl Bond ETFFUND · shares +9.2% · price −0.6% | 1.7% | $7.11B | −$37.1M | ||||||||
| AlibabaADR · shares +13% · price −8.3% | 1.3% | $5.33B | −$425.8M | ||||||||
| Unitedhealth Group IncCOMMON · shares +6.2% · price −15.2% | 1.0% | $4.36B | −$734.3M | ||||||||
| AlphabetCOMMON · shares +0.6% · price −13.0% | 1.0% | $4.31B | −$641.9M | ||||||||
| Ishares Msci Eafe ETFFUND · shares −3.5% · price −23.0% | 0.99% | $4.22B | −$1.26B | ||||||||
| Ishares 7-10 Year Treasury BFUND · shares −14% · price +10.2% | 0.92% | $3.91B | +$362.2M | ||||||||
| TSMCADR · shares +6.2% · price −17.7% | 0.84% | $3.59B | −$730.2M | ||||||||
| AlphabetCOMMON · shares −5.7% · price −13.2% | 0.80% | $3.39B | −$517.7M | ||||||||
| Bristol-Myers Squibb CoCOMMON · shares +17% · price −13.2% | 0.79% | $3.37B | −$435.1M | ||||||||
| MastercardCOMMON · shares +2.7% · price −19.1% | 0.78% | $3.32B | −$763.0M | ||||||||
| Johnson & JohnsonCOMMON · shares −6.9% · price −10.1% | 0.71% | $3.03B | −$340.1M | ||||||||
| Nextera Energy IncCOMMON · shares −4.5% · price −0.6% | 0.70% | $3.00B | −$19.2M | ||||||||
| Texas InstrumentsCOMMON · shares +1.7% · price −22.1% | 0.70% | $2.99B | −$835.5M | ||||||||
| Ishares Core U.S. AggregateFUND · shares +68% · price +2.7% | 0.66% | $2.83B | +$43.8M | ||||||||
| Home Depot IncCOMMON · shares +1.4% · price −14.5% | 0.65% | $2.78B | −$465.5M | ||||||||
| Jpmorgan Betabuilders CanadaFUND · shares −0.8% · price −26.9% | 0.64% | $2.72B | −$1.00B | ||||||||
| Bk Of America CorpCOMMON · shares +4.5% · price −39.7% | 0.63% | $2.70B | −$1.70B | ||||||||
| Verizon Communications IncCOMMON · shares +0.3% · price −12.5% | 0.63% | $2.69B | −$383.1M | ||||||||
| SPDR S&P 500 ETF TrCALLOPTION · shares +12% | 0.62% | $2.62B | — | ||||||||
| Coca Cola CoCOMMON · shares −6.2% · price −20.1% | 0.61% | $2.60B | −$651.2M | ||||||||
| Procter & Gamble CoCOMMON · shares +18% · price −11.9% | 0.58% | $2.47B | −$284.1M | ||||||||
| Total · 5,335 positions | 100% | $425.90B | −$91.48B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2019 to Q1 2020: 4,174 stocks held throughout, down $91.48B (−20.5%).
- Amazon+$401.1M+6%
- Ishares 7-10 Year Treasury B+$362.2M+10%
- Tesla+$268.1M+25%
- Ishares 20 Year Treasury Bo+$267.3M+22%
- Netflix+$239.6M+16%
- Apple−$1.18B−13%
- Ishares Msci Eafe ETF−$1.26B−23%
- Chevron Corp New−$1.36B−40%
- Bk Of America Corp−$1.70B−40%
- SPDR S&P 500 ETF Trust−$4.55B−20%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 144 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.81T+16% | SEC ↗ |
| Q1 2026 | May 13, 2026 (amended) | $1.56T−2% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $1.59T−52% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 (amended) | $3.34T+118% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $1.53T+12% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.37T+2% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.34T−49% | SEC ↗ |
| Q3 2024 | Nov 8, 2024 (amended) | $2.63T+8% | SEC ↗ |
| Q2 2024 | Aug 12, 2024 (amended) | $2.44T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 (amended) | $2.37T+14% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $2.08T+130% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $906.36B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $920.27B+12% | SEC ↗ |
| Q1 2023 | May 18, 2023 (amended) | $820.88B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $758.55B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $696.38B−3% | SEC ↗ |
| Q2 2022 | Aug 11, 2022 | $717.86B−14% | SEC ↗ |
| Q1 2022 | May 11, 2022 | $830.28B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 (amended) | $865.90B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $808.68B−4% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $838.21B+12% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $749.21B+10% | SEC ↗ |
| Q4 2020 | Feb 19, 2021 (amended) | $680.63B+14% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 (amended) | $595.09B+15% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $518.17B+22% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $425.90B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $536.28B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $502.15B−2% | SEC ↗ |
| Q2 2019 | Aug 7, 2019 | $511.43B+4% | SEC ↗ |
| Q1 2019 | May 7, 2019 | $489.55B+13% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 | $432.49B−17% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 (amended) | $522.20B+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $486.35B+4% | SEC ↗ |
| Q1 2018 | May 10, 2018 | $466.55B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $474.64B+5% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $453.26B+4% | SEC ↗ |
| Q2 2017 | Aug 9, 2017 | $437.53B−0% | SEC ↗ |
| Q1 2017 | May 10, 2017 | $437.58B+5% | SEC ↗ |
| Q4 2016 | Feb 6, 2017 | $416.17B+2% | SEC ↗ |
| Q3 2016 | Nov 4, 2016 | $406.33B+1% | SEC ↗ |
| Q2 2016 | Aug 8, 2016 | $401.04B+3% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $390.67B | SEC ↗ |